Custom AntibodiesAntibody development, production and purificationSmartEnzymes for BiopharmaceuticalsThe SmartEnzymes portfolio consists of enzymatic products and technologies designed to improve the efficacy and throughput in analytical or preparative workflows for complex biopharmaceuticals such as antibodies, Fc-fusion proteins, complex glycoproteins or antibody conjugates.Learn more about our products and services! Applications for SmartEnzymesWhether you are working with research and development or routine quality control of biopharmaceuticals, our products are designed to deliver the best results in the most efficient way.Find your application and the SmartEnzymes that suit your project in an online meeting together with our enzyme experts! Resources - Find out moreInterested in more applications or which SmartEnzymes to use in your project? We share a wide range of resources including posters, application notes and brochures that showcase our variety of product formats and the different applications for SmartEnzymes. References HighlightsPurification of antibody fragments via interaction with detergent micellar aggregates2021-06-03Gunasekaran Dhandapani, Ellen Wachtel, Ishita Das, Mordechai Sheves & Guy PatchornikThe monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies2021-05-28Richard Copin, Alina Baum, Elzbieta Wloga, Kristen E. Pascal, Stephanie Giordano, Benjamin O. Fulton, Anbo Zhou, Nicole Negron, Kathryn Lanza, Newton Chan, Angel Coppola, Joyce Chiu, Min Ni, Yi Wei, Gurinder S. Atwal, Annabel Romero Hernandez, Kei Saotome, Yi Zhou, Matthew C. Franklin, Andrea T. Hooper, Shane McCarthy, Sara Hamon, Jennifer D. Hamilton, Hilary M. Staples, Kendra Alfson, Ricardo Carrion, Jr., Shazia Ali, Thomas Norton, Selin Somersan-Karakaya, Sumathi Sivapalasingam, Gary A. Herman, David M. Weinreich, Leah Lipsich, Neil Stahl, Andrew J. Murphy, George D. Yancopoulos, Christos A. KyratsousState-of-the-Art Native Mass Spectrometry and Ion Mobility Methods to Monitor Homogeneous Site-Specific Antibody-Drug Conjugates Synthesis2021-05-24Evolène Deslignière, Anthony Ehkirch, Bastiaan L. Duivelshof, Hanna Toftevall, Jonathan Sjögren, Davy Guillarme, Valentina D’Atri, Alain Beck, Oscar Hernandez-Alba, and Sarah CianféraniAll References»Legal DisclaimersAll rights reserved. Genovis products may be covered by one or more patents, trademarks and copyrights owned or controlled by Genovis AB. For more information about commercial rights, please contact the Genovis team at licensing@genovis.com.Genovis products are intended for research use only. They are not intended to be used for therapeutic or diagnostic purposes in humans or animals. All goods and services are sold subject to Genovis’ General Terms and Conditions of Sale.© Genovis ABMore information about legal disclaimers » We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok